CATALOGO DEI PRODOTTI DELLA RICERCA

ADAMI, Silvano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.679
EU - Europa 25.412
AS - Asia 16.928
SA - Sud America 2.125
AF - Africa 365
Continente sconosciuto - Info sul continente non disponibili 298
OC - Oceania 30
Totale 82.837
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.208
GB - Regno Unito 8.768
SG - Singapore 7.490
RU - Federazione Russa 6.716
CN - Cina 4.748
IT - Italia 1.927
BR - Brasile 1.703
DE - Germania 1.681
FR - Francia 1.483
SE - Svezia 1.411
VN - Vietnam 1.364
HK - Hong Kong 1.346
FI - Finlandia 1.248
IE - Irlanda 1.097
KR - Corea 575
UA - Ucraina 538
BD - Bangladesh 276
TR - Turchia 260
CA - Canada 218
NG - Nigeria 189
IN - India 174
JP - Giappone 165
AR - Argentina 134
MX - Messico 108
NL - Olanda 97
IQ - Iraq 89
BE - Belgio 81
EC - Ecuador 80
ID - Indonesia 71
ES - Italia 62
PL - Polonia 62
ZA - Sudafrica 57
CO - Colombia 50
CL - Cile 48
AT - Austria 41
VE - Venezuela 41
PK - Pakistan 39
IR - Iran 37
UZ - Uzbekistan 35
JM - Giamaica 33
IL - Israele 32
SA - Arabia Saudita 29
CZ - Repubblica Ceca 28
MA - Marocco 25
AU - Australia 24
CR - Costa Rica 24
PY - Paraguay 23
KE - Kenya 22
PE - Perù 22
PH - Filippine 21
EG - Egitto 20
NP - Nepal 19
LT - Lituania 18
MY - Malesia 16
AE - Emirati Arabi Uniti 15
BG - Bulgaria 15
CH - Svizzera 15
JO - Giordania 14
RO - Romania 14
TN - Tunisia 14
UY - Uruguay 14
NI - Nicaragua 13
HN - Honduras 12
AZ - Azerbaigian 11
DO - Repubblica Dominicana 11
AL - Albania 10
PS - Palestinian Territory 10
TH - Thailandia 10
DZ - Algeria 9
EE - Estonia 9
KG - Kirghizistan 9
LV - Lettonia 9
PR - Porto Rico 9
SK - Slovacchia (Repubblica Slovacca) 9
BO - Bolivia 8
GT - Guatemala 8
HU - Ungheria 8
KZ - Kazakistan 8
QA - Qatar 8
TT - Trinidad e Tobago 8
GE - Georgia 7
HR - Croazia 7
MD - Moldavia 7
NO - Norvegia 7
OM - Oman 7
PT - Portogallo 7
SV - El Salvador 7
TW - Taiwan 7
A2 - ???statistics.table.value.countryCode.A2??? 6
GR - Grecia 6
LB - Libano 6
NZ - Nuova Zelanda 6
PA - Panama 6
BA - Bosnia-Erzegovina 5
BB - Barbados 5
RS - Serbia 5
SN - Senegal 5
AM - Armenia 4
CM - Camerun 4
DK - Danimarca 4
Totale 82.471
Salva come PNG Salva come JPEG
Città #
Dallas 8.351
Southend 7.930
Jacksonville 4.321
Singapore 4.177
Ashburn 3.055
Chandler 2.545
San Jose 2.301
Woodbridge 2.091
Moscow 1.782
Ann Arbor 1.657
Hong Kong 1.328
Houston 1.206
Dublin 1.092
The Dalles 842
Council Bluffs 807
Verona 722
Beijing 582
Wilmington 552
Lawrence 535
Princeton 535
Los Angeles 448
Ho Chi Minh City 437
Nanjing 427
New York 407
Jinan 392
Shenyang 339
Buffalo 327
Hanoi 306
Helsinki 239
Boardman 232
Sindelfingen 231
Santa Clara 227
Hebei 222
Milan 218
São Paulo 194
Abuja 186
Tianjin 185
Changsha 164
Tokyo 146
Providence 138
Nanchang 135
Dong Ket 134
Columbus 130
Zhengzhou 123
Haikou 121
Ningbo 113
Hangzhou 112
Guangzhou 111
Jiaxing 111
Taizhou 100
Annandale 92
Redondo Beach 92
Orem 88
Munich 85
Philadelphia 83
Chicago 82
Toronto 76
Brussels 74
Falls Church 74
Brooklyn 72
Norwalk 70
San Francisco 70
Taiyuan 70
Frankfurt am Main 69
Rome 68
Atlanta 67
Las Vegas 65
Phoenix 63
Seattle 62
Detroit 59
Rio de Janeiro 59
Fairfield 56
Lanzhou 54
Denver 53
Warsaw 53
Amsterdam 50
Da Nang 50
Chennai 49
London 48
Washington 48
Bologna 47
Lancaster 47
Fuzhou 46
Brasília 41
Dearborn 41
Turku 38
Belo Horizonte 37
Düsseldorf 36
Haiphong 36
Mexico City 36
Montreal 36
Paris 36
Redmond 35
Boston 33
Falkenstein 33
Orani 33
Quito 31
Stockholm 31
Biên Hòa 30
Curitiba 30
Totale 55.800
Salva come PNG Salva come JPEG
Nome #
1,25-dihydroxy vitamin D in primary hyperparathyroidism 3.885
1,25 (OH) 2D3 stimulates and bisphosphonates inhibit fibronectin release by human microphages. 3.778
Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis 521
Teriparatide and denosumab combination therapy and skeletal metabolism 362
Artrite Reumatoide e Metabolismo Minerale 280
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 279
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 273
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 271
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 267
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 263
[Serum calcium evaluation and incidence of primary hyperparathyroidism in hospitalized patients (author's transl)] 262
PAEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH GROUP A STREPTOCOCCAL INFECTION (PANDAS): CARDIAC AND ARTICULAR INVOLVEMENT 262
[Incidence of thyroid diseases in primary hyperparathyroidism] 258
25-OH-D metabolism in primary hyperparathyroidism 257
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 257
[Rational bases for the treatment of osteoporosis] 253
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 253
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 253
12 month-retrospective analysis of two different rituximab retreatment regimens in rheumatoid arthritis:retreatment at clinical relapse Vs 6 (th) month fixed retreatment 250
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 249
Il trattamento del morbo di Paget con calcitonina umana: influenza della secrezione paratoidea e dei titoli di anticorpi anti-calcitonina (umana e porcina) 248
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 247
Age-related bone loss in postmenopausal women 246
[Acid-base balance in primary hyperparathyroidism] 244
[Therapeutic strategies in osteoporosis: whom and when to treat] 239
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] 238
12 month-retrospective analysis of two different Rituximab pretreatment regimens in Rheumatoid Arthritis: retreatment at clinical relapse versus 6th month fixed pretreatment. 237
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 237
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 234
[Risk factors for hip fracture in elderly persons]. 231
Effects of therapeutic doses of salbutamol alone and combined with beclomethasone dipropionate on airway responsiveness and cyclic AMP plasma levels in asthmatic patients 227
[Studies on the therapeutic efficacy of a new diuretic combination in patients with edema of hepatic and cardiac etiology] 227
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 225
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 225
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 221
Analisi di linkage di geni candidati per densità minerale 220
[Comparative studies of the behavior of blood calcium and urinary hydroxyproline after infusion of calcitonin and glucagon in patients with Paget's disease] 217
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 216
[Pathophysiology of osteoarthritis: perspectives] 216
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 213
Fasting serum gastrin in primary hyperparathyroidism and in chronic hypercalcemia 212
Bone involvement and osteoporosis in mastocytosis. 212
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. 210
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 210
Serum thyroid hormone concentrations and weight loss relationships in eight obese women during semistarvation 206
Aberration in vitamin D metabolism during mianserin treatment [letter] 206
[Italian guidelines for the diagnosis and treatment of Paget's disease of bone]. 206
Power Doppler ultrasonographic findings in healthy pediatric entheses 205
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 205
Incidenza di ipovitaminosi D nel Nord Italia 202
Growth Hormone in Combination with Bisphosphonate Treatment in Osteogenesis Imperfecta. 202
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 199
Primary hyperparathyroidism: diagnostic value of a model of multivariate statistical analysis 198
Bone involvement in patient with clonal mast cell disorders 197
Prevalence and incidence of rheumatoid arthritis in Italy. 197
Antinuclear antibody profile in systemic sdclerosis patients who are negative for anticentromere and anti-topoisomerase I specificities 195
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 195
L'attività xantino-ossidasica epatocitaria nelle siderocromatosi primitive e secondarie 194
Association between bone mineral density and serum lipid in men 192
Valutazione ecografia con power doppler delle entesi in età pediatrica 192
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 190
[Antinflammatory therapy and cardiovascular risk: a consensus view]. 190
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 189
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 189
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 189
Response of Paget's disease to human calcitonin in patients resistant to porcine calcitonin 187
[Ketotifen in the therapy of bronchial asthma] 187
Rapporti tra sistema immune e metabolismo osseo 187
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 187
Allergy and the bone: unexpected relationships 186
Osteopetrosi 185
A morphometric ultrastructural study of unenvolved parathyroid glands in primary iperparathyroidism 182
Adverse effects of bisphosphonates. A comparative review 181
Sustained vertebral fracture risk reduction after withdrowal of teriparatide in postmenopausal women with osteoporosis 181
Osteoporosis treatment: why ibandronic acid? 181
Simultaneous measurement of 1.25-dihydroxy-vitamin D, 24.25-dihydroxy-vitamin D and 25-hydroxy-vitamin D from a single two milliliters serum specimen. Preliminary clinical application 180
Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases. 179
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 179
Discriminant analysis in the differential diagnosis of hypercalcaemia 178
Digital Amputation in Systemic Sclerosis: Prevalence and Clinical Associations. A Retrospective Longitudinal Study. 178
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 178
Valore del dosaggio radioimmunologico del paratormone plasmatico nella diagnosi di iperparatiroidismo primitivo 177
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 177
[Diacetylrhein in the treatment of degenerative arthropathies] 176
Sclerostin and DKK1 in primary hyperparathyroidism. 176
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 176
DXA bone mineral density in males: retrospective study in real life. 175
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 175
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women 175
ARTROPATIE DISMETABOLICHE 174
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 174
Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment 173
Il dosaggio del calcio ionizzato nelle alterazioni del metabolismo fosfo-calcico 173
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 173
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 173
[Relations between polycystic ovary and idiopathic hirsutism] 172
Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism 172
Acute effects of deflazacort and prednisone on rates of mineralization and bone formation 172
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 171
Coxibs: a significant therapeutic opportunity. 171
Totale 28.544
Salva come PNG Salva come JPEG
Categoria #
all - tutte 248.509
article - articoli 231.901
book - libri 0
conference - conferenze 8.201
curatela - curatele 0
other - altro 1.443
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.964
Totale 497.018
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.516 0 0 0 133 261 216 41 234 175 122 434 900
2022/20237.834 701 526 976 1.242 762 1.856 62 512 782 57 250 108
2023/20243.293 203 293 303 496 448 385 120 257 34 108 407 239
2024/20259.027 674 792 349 1.397 417 160 359 528 1.304 616 540 1.891
2025/202629.561 1.929 3.063 6.535 3.370 4.991 1.888 2.630 1.313 1.855 1.052 380 555
2026/20274.568 348 1.051 1.564 1.605 0 0 0 0 0 0 0 0
Totale 82.837